The prospect of targeting inflammation to treat residual cardiovascular risk using the monoclonal antibody canakinumab (Ilaris) appears to be slim to none in the wake of recent decisions from ...
Figure 1: Summary of data resources and mappings between them. Figure 2: Enrichment of target genes for drugs approved in the United States or the European Union. Figure 3: Overlap between drug ...
Money is such a great score keeper. Profit is the purpose of business. It is the end-all be-all indicator of business success. Alas, profit is not a perfect indicator of progress. It can send very ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results